ABSTRACT
When Merck began its AIDS research in 1986, pharmaceutical companies had been savaged by activists, patient advocates, the research community, the government, and the news media for failing to do enough research and for pricing their drugs too high. Demonstrations were held at several company headquarters. There was violence.
